[1] Torre LA, Bray F, Siegel RL,et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015,65: 87-108.
[2] Bruix J,Sherman M.Management of hepatocellular carcinoma.Hepatology (Baltimore, Md.),2005,42:1208-1236.
[3] 金鹏,孙钢.肝癌消融治疗的研究进展.中华消化病与影像杂志(电子版),2016,6:97-102.
[4] Lencioni R, Crocetti L. Image-guided thermal ablation of hepatocellular carcinoma. Crit Rev Oncol Hematol. 2008,66:200-207.
[5] Shankar S,vanSonnenberg E,Morrison PR,et al.Combined radiofrequency and alcohol injection for percutaneous hepatic tumor ablation. AJR Am J Roentgenol,2004,183:1425-1429.
[6] Park JG, Park SY, Tak WY,et al. Early complications after percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1,843 ablations in 1,211 patients in a single centre: experience over 10 years. Clin Radiol. 2017,72:692
[7] Ma W,Chen X,Yuan Y. T-cell-associated immunotherapy: a promising strategy for the treatment of hepatocellular carcinoma. Immunotherapy.2017 9:523-525.
[8] 田春宇.非小细胞肺癌中TAMs的状态及TNF-α与EGFR的表达. 承德医学院,2014.
[9] Cha H,Lee EJ,Seong J. Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy. World J Gastroenterol.2017 23:2077-2085. |
